Yaron Raiter

Efficacy and safety of MYL‐1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study

Thomas Blevins, Abhijit Barve, Yaron Raiter et al. · Diabetes Obesity and Metabolism · 2019 · 33 citations · Full text

Efficacy and safety of MYL‐1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase III INSTRIDE 2 study

Thomas Blevins, Abhijit Barve, Bin Sun et al. · Diabetes Obesity and Metabolism · 2018 · 28 citations · Full text

Visually evoked cerebral vasomotor response in smoking and nonsmoking young adults, investigated by functional transcranial Doppler

László Oláh, Yaron Raiter, Claudia Candale et al. · Nicotine & Tobacco Research · 2008 · 23 citations · Full text

Pharmacokinetic and pharmacodynamic bioequivalence of biosimilar <scp>MYL‐1601D</scp> with <scp>US</scp> and <scp>European</scp> insulin aspart in healthy volunteers: A randomized, double‐blind, crossover, euglycaemic glucose clamp study

Ulrike Hövelmann, Yaron Raiter, Anoop Chullikana et al. · Diabetes Obesity and Metabolism · 2021 · 13 citations · Full text